Browse by author
Lookup NU author(s): Dr John Anderson, Professor John LunecORCiD, Dr Brian Angus
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The inhibitor of growth (ING) genes (ING1-4) probably descend from tumour suppressor genes. ING1 was the first to be identified and later isolated using an approach to detect genes whose expression is suppressed in cancer. The others were isolated through homology and similarity searches in human and mouse databases. All members contain a plant homeodomain involved in macromolecule recognition. Apart from the extensively studied ING1, little is known about the number of transcripts encoded by the other members or their gene structure. ING1 encodes several differentially spliced mRNAs, which may produce a family of proteins. The most widely expressed protein isoform is p33INGb1, which is involved in restriction of cell growth and proliferation, apoptosis, tumour anchorage independent growth, cellular senescence, maintenance of genomic stability, and modulation of cell cycle checkpoints. ING1 gene mutation is uncommon in cancer, although the subcellular localisation of p33INGb1 may have an effect on its function. The p33INGb1 cellular compartmental shift from the nucleus to the cytoplasm may cause loss of normal cellular function, and may play a central role in the pathogenesis of several cancers.
Author(s): Nouman, G., Anderson, J.J., Lunec, J., Angus, B.
Publication type: Review
Publication status: Published
Journal: Journal of Clinical Pathology
Year: 2003
Volume: 56
Issue: 7
Pages: 491-496
Print publication date: 01/07/2003
ISSN (print): 0021-9746
ISSN (electronic): 1472-4146
URL: http://dx.doi.org/10.1136/jcp.56.7.491
DOI: 10.1136/jcp.56.7.491
PubMed id: 12835293